Result of EGM

Provexis PLC
10 April 2007


10 April 2007

                                  PROVEXIS PLC

                         ('PROVEXIS' OR 'THE COMPANY')

                               Result of Meeting

Provexis plc, the nutraceutical company that develops scientifically-proven
functional and medical foods, announces that further to its announcement of 16
March 2007, all of the resolutions proposed at the Extraordinary General Meeting
held earlier today were duly passed.

It is expected that the 143,316,664 new Ordinary Shares of 1p each in the
Company placed at 1.5p per share with institutional and other investors, and
certain of the Company's Directors, will be admitted to AIM on Thursday 12 April
2007. Following Admission, the Company will have in issue 394,355,136 Ordinary
Shares of 1p each.

Certain terms used in this announcement are defined and have the same meaning as
in the Company's announcement of 16 March 2007.


ENQUIRIES

Provexis plc                         Tel. [phone]
Stephen Moon, CEO

Arbuthnot                            Tel. [phone]
Tom Griffiths
Alasdair Younie


END



                      This information is provided by RNS
            The company news service from the London Stock Exchange